Global Biosimilars Market Is Anticipated to Quadruple During the Forecast Period with a Growth Rate of 26.87%
According to a new market research report " Biosimilars Market By Type (Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon, Calcitonin), By Technology (, Mass Spectroscopy, Chromatography And Others), By Application (Oncology And Blood Diseases, Growth Hormone Deficiencies And Others), By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2017-2022", published by MarketDataForecast. The Global Biosimilars Market was priced USD 4,760.0 million in 2016 and...
View full press release